(Q44718272)

5 December 2017

title

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent (English)

1 reference

5 December 2017

1 reference

endometrial hyperplasia

1 reference

Session DR

1

1 reference

5 December 2017

Kalli KR

2

1 reference

5 December 2017

Tummon IS

3

1 reference

5 December 2017

Damario MA

4

1 reference

5 December 2017

Dumesic DA

5

1 reference

5 December 2017

publication date

1 October 2003

1 reference

Gynecological Endocrinology

5 December 2017

published in

1 reference

5 December 2017

volume

17

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

405-407

1 reference

Association of Exogenous Estrogen and Endometrial Carcinoma

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

A case-control study of diabetes mellitus and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Mechanism by which metformin reduces glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

Suppressed expression of insulin‐like growth factor binding protein‐1 mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590312331290298

10.1080/09513590312331290298

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference